{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T14:22:57Z","timestamp":1778595777669,"version":"3.51.4"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T00:00:00Z","timestamp":1615766400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP20fk0310113"],"award-info":[{"award-number":["JP20fk0310113"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP16fk0310501"],"award-info":[{"award-number":["JP16fk0310501"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological Sciences"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.jphs.2021.03.004","type":"journal-article","created":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T00:47:54Z","timestamp":1616201274000},"page":"82-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effects of islatravir (4\u2032-ethynyl-2-fluoro-2\u2032-deoxyadenosine or EFdA) on renal tubular cells and islatravir's interactions with organic anion transporters"],"prefix":"10.1016","volume":"146","author":[{"given":"Meika","family":"Kaneko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshie","family":"Reien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanae","family":"Morio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Fukuuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoko","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuri","family":"Hirayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyo","family":"Kuwata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Mitsuya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohiko","family":"Anzai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10148","key":"10.1016\/j.jphs.2021.03.004_bib1","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(18)31311-4","article-title":"Hiv","volume":"392","author":"Ghosn","year":"2018","journal-title":"The Lancet"},{"issue":"8","key":"10.1016\/j.jphs.2021.03.004_bib2","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1128\/AAC.00277-07","article-title":"Activity against human immunodeficiency virus type 1, intracellular metabolism, and effects on human DNA polymerases of 4'-ethynyl-2-fluoro-2'-deoxyadenosine","volume":"51","author":"Nakata","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.jphs.2021.03.004_bib3","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1128\/AAC.00270-09","volume":"53","author":"Hattori","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.jphs.2021.03.004_bib4","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3851\/IMP2697","article-title":"Delayed emergence of HIV-1 variants resistant to 4'-ethynyl-2-fluoro-2'-deoxyadenosine: comparative sequential passage study with lamivudine, tenofovir, emtricitabine and BMS-986001","volume":"19","author":"Maeda","year":"2014","journal-title":"Antivir Ther"},{"issue":"51","key":"10.1016\/j.jphs.2021.03.004_bib5","doi-asserted-by":"crossref","first-page":"35681","DOI":"10.1074\/jbc.M109.036616","article-title":"Mechanism of inhibition of HIV-1 reverse transcriptase by 4'-Ethynyl-2-fluoro-2'-deoxyadenosine triphosphate, a translocation-defective reverse transcriptase inhibitor","volume":"284","author":"Michailidis","year":"2009","journal-title":"J\u00a0Biol Chem"},{"issue":"10","key":"10.1016\/j.jphs.2021.03.004_bib6","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.chembiol.2018.07.014","article-title":"The high genetic barrier of EFdA\/MK-8591 stems from strong interactions with the active site of drug-resistant HIV-1 reverse transcriptase","volume":"25","author":"Takamatsu","year":"2018","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.jphs.2021.03.004_bib7","unstructured":"Matthews RP, Sch\u00fcrmann D, Rudd DJ, et\u00a0al. Single doses as low as 0.5 mg of the novel NRTTI MK-8591 suppress HIV for at least seven days. 9th IAS conference on HIV science (IAS 2017), july 23-26, 2017, paris."},{"issue":"9987","key":"10.1016\/j.jphs.2021.03.004_bib8","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1016\/S0140-6736(15)60616-X","article-title":"Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials","volume":"385","author":"Sax","year":"2015","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.jphs.2021.03.004_bib9","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1046\/j.1523-1755.1999.00789.x","article-title":"Role of organic anion transporter 1 (OAT1) in cephaloridine (CER)-induced nephrotoxicity","volume":"56","author":"Takeda","year":"1999","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.jphs.2021.03.004_bib10","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s11095-006-9196-x","article-title":"Renal transport of adefovir, cidofovir, and tenofovir by SLC22A family members (hOAT1, hOAT3, and hOCT2)","volume":"24","author":"Uwai","year":"2007","journal-title":"Pharm Res (N Y)"},{"issue":"4","key":"10.1016\/j.jphs.2021.03.004_bib11","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/QAI.0b013e3182965d45","article-title":"Antiviral activity, safety, and pharmacokinetics\/pharmacodynamics of tenofovir alafenamide as 10-day monotherapy in HIV-1-positive adults","volume":"63","author":"Ruane","year":"2013","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jphs.2021.03.004_bib12","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s002040050275","article-title":"Cisplatin-induced toxicity in immortalized renal cell lines established from transgenic mice harboring temperature sensitive SV40 large T-antigen gene","volume":"70","author":"Hosoyamada","year":"1996","journal-title":"Arch Toxicol"},{"issue":"1","key":"10.1016\/j.jphs.2021.03.004_bib13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1046\/j.1523-1755.2003.00710.x","article-title":"Urate transport via human PAH transporter hOAT1 and its gene structure","volume":"63","author":"Ichida","year":"2003","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.jphs.2021.03.004_bib14","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1124\/jpet.102.034330","article-title":"Characterization of methotrexate transport and its drug interactions with human organic anion transporters","volume":"302","author":"Takeda","year":"2002","journal-title":"J\u00a0Pharmacol Exp Therapeut"},{"issue":"9","key":"10.1016\/j.jphs.2021.03.004_bib15","doi-asserted-by":"crossref","first-page":"895","DOI":"10.2116\/analsci.31.895","article-title":"Analysis of intra- and extracellular levels of purine bases, nucleosides, and nucleotides in HepG2 cells by high-performance Liquid chromatography","volume":"31","author":"Fukuuchi","year":"2015","journal-title":"Anal Sci"},{"key":"10.1016\/j.jphs.2021.03.004_bib16","article-title":"Title: once-weekly oral dosing of MK-8591 protects male Rhesus macaques from intrarectal SHIV109CP3 challenge","author":"Markowitz","year":"2019","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jphs.2021.03.004_bib17","doi-asserted-by":"crossref","DOI":"10.1007\/s11904-020-00486-2","article-title":"Novel antiretroviral agents","author":"Cambou","year":"2020","journal-title":"Curr HIV AIDS Rep"},{"issue":"33","key":"10.1016\/j.jphs.2021.03.004_bib18","doi-asserted-by":"crossref","first-page":"9274","DOI":"10.1073\/pnas.1605223113","article-title":"Structural basis of HIV inhibition by translocation-defective RT inhibitor 4'-ethynyl-2-fluoro-2'-deoxyadenosine (EFdA)","volume":"113","author":"Salie","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.jphs.2021.03.004_bib19","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1208\/s12248-013-9465-7","article-title":"Organic cation transporter OCTs (SLC22) and MATEs (SLC47) in the human kidney","volume":"15","author":"Motohashi","year":"2013","journal-title":"AAPS J"},{"issue":"1","key":"10.1016\/j.jphs.2021.03.004_bib20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/ki.2010.337","article-title":"New insights into the mechanism of aminoglycoside nephrotoxicity: an integrative point of view","volume":"79","author":"Lopez-Novoa","year":"2011","journal-title":"Kidney Int"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861321000244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861321000244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T14:02:00Z","timestamp":1778594520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347861321000244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S1347861321000244"],"URL":"https:\/\/doi.org\/10.1016\/j.jphs.2021.03.004","relation":{},"ISSN":["1347-8613"],"issn-type":[{"value":"1347-8613","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of islatravir (4\u2032-ethynyl-2-fluoro-2\u2032-deoxyadenosine or EFdA) on renal tubular cells and islatravir's interactions with organic anion transporters","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphs.2021.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society.","name":"copyright","label":"Copyright"}]}}